Press Releases
EndoGastric Solutions announces 100 Million Lives Now Covered for Transoral Incisionless Fundoplication Procedure
Policy decisions by federal and commercial payers have expanded coverage for the TIF 2.0 procedure in 2018, extending access to effective long-term control of acid reflux symptoms REDMOND, Wash. – Federal and commercial payer plans responsible for over 100 million...
EndoGastric® Solutions Debuts EsophyX® Z+ Device for Transoral Incisionless Fundoplication (TIF) Procedures
New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes. REDMOND, Wash. – EsophyX® Z+ device offers expanded endoscope compatibility and joins EndoGastric Solutions’® portfolio of specialized...
EndoGastric® Solutions Announces Further Expansion of Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) 2.0 Procedure
Expanded Medicare coverage and update to facility reimbursement increases patient access to non-surgical alternative for long-term control of acid reflux symptoms REDMOND, Wash. (November 14, 2017) - Medicare beneficiaries in 23 additional states have been granted...
EndoGastric® Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) Procedure
Effective alternative for long-term control of acid reflux symptoms will now be available to over 60% of Medicare patients REDMOND, Wash. - Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless...
EndoGastric Solutions Announces 12-month Data Validating Hiatal Hernia Repair Prior to Transoral Incisionless Fundoplication (TIF®) as a Durable GERD Treatment Option
Study participants saw 80 percent improvement for heartburn and regurgitation one-year post procedure when hiatal hernia and gastroesophageal valve were repaired sequentially REDMOND, Wash. - EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy...
EndoGastric Solutions announces Coverage Verification by HealthNet for TIF® 2.0 Procedure with EsophyX® Device
Reflux sufferers in Arizona, California, Oregon and Washington now have access to less invasive reflux treatment option.
EndoGastric® Solutions Expands Commercial Leadership Team to Meet Increased Demand for TIF® Procedure for Reflux
EndoGastric Solutions®, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the addition of two senior executives to its leadership team: Martin Reid, Vice President of Sales, and Ted Stephens, Vice President of Marketing and Professional Education.
EndoGastric Solutions Launches EsophyX® Z Technology for the TIF® 2.0 Procedure in Europe
Early Access Program starts in Italy with CE-marked device to meet reflux treatment demand REDMOND, Wash. – EndoGastric Solutions®, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the...
EndoGastric Solutions to Host Product Theater Session on the TIF® Procedure at Digestive Disease Week® (DDW) 2017
Plus, ASGE Special Interest Group meeting to also highlight Endoluminal Therapy for GERD EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company will host an educational...